Irish CRO Icon rolls out digital platform developed with Dimension Data

HPE has acquired AI and big data company BlueData for an undisclosed sum (Image PeopleImages / iStockPhoto)
Dublin-based CRO Icon had adopted a new digital platform developed with Dimension Data designed to enhance efficiency and productivity of its clients’ drug and medical device pipelines. (PeopleImages/iStockPhoto)

Dublin-based CRO Icon had adopted a new digital platform developed with Dimension Data designed to enhance efficiency and productivity of its clients’ drug and medical device pipelines.

The platform has been launched throughout the CRO to help support digital trials and patient interaction so that medical professionals can reach those who need it, a Dimension Data spokesperson said in an e-mail.

The platform was designed to aid in reducing complexity and cost for drug and device companies in bring new products to market.

CONFERENCE

AI Innovations for Life Science and Healthcare Summit East

Join the expert speaking faculty of over 30 life science, healthcare, and tech professionals on June 13–14, 2019, in Philadelphia, as we elevate clinical trial operations, healthcare outcomes, and supply chain implementation through AI. Use Discount Code 796819FIERCE to save 15% off the standard registration rate.

Last year, Icon launched a new, paperless solution for managing the clinical investigator financial disclosure forms mandated by the FDA. Known as Firecrest Financial Disclosure software, it allows sponsors to electronically gather, distribute, track and manage completion of the forms required under the regulatory agency’s rules. The Irish company hopes the system will lower the risks of regulatory noncompliance and reduce administrative costs versus traditional distribution and tracking.

Read more on

Suggested Articles

WIRB-Copernicus Group has added two new executives to its roster as it expands its Global Research Network of investigative sites.

Incoming FDA Commissioner Ned Sharpless used his first official talk to ensure we all know he’s not looking to tear up Scott Gottlieb’s legacy.

Charles River Labs and the CHDI Foundation have signed a five-year extension for their Huntington’s disease work.